CYTODYN INC Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (42)

Latest Posts

About This Stock More About This Stock
E Cytodyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Article By: Moon Kil Woong
Friday, September 18, 2020 12:10 PM EDT
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
In this article: CYDY Also: IMMU, GILD
Read
E CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Article By: Moon Kil Woong
Monday, August 3, 2020 8:00 PM EDT
Cytodyn, is set to move on positive information and this article gives updated information on why it may move in the near term and an update on their Covid drug trial.
In this article: CYDY Also: GILD, ICPT
Read
CytoDyn Files Application With Nasdaq For Uplist
Article By: TalkMarkets Newswire
Wednesday, July 15, 2020 5:53 PM EDT
CytoDyn Inc., announced today it recently filed a comprehensive listing application package with The Nasdaq Stock Market to request an uplisting of the Company’s common stock.
In this article: CYDY
Read
E HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Article By: Moon Kil Woong
Friday, July 3, 2020 11:10 AM EDT
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
In this article: CYDY, GILD Also: MRK
Read
CytoDyn And Samsung BioLogics Enter Into Agreement To Manufacture $1 Billion Worth Of Leronlimab (PRO 140) To Meet Expected Demand For Future Revenues Post-Approval
Article By: TalkMarkets Newswire
Tuesday, April 2, 2019 5:00 AM EDT
CytoDyn, a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced the execution of a comprehensive strategic agreement with Samsung BioLogics.
In this article: CYDY
Read

PARTNER HEADLINES

Latest Tweets for $CYDY

No tweets yet!

$CYDY

CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Currency Trader 9/24/2020 11:14:44 PM

Perhaps I should have listened to you and stuck to forex which I know. $CYDY is down quite a bit since I first read this.

Cytodyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Adam Reynolds 9/23/2020 11:52:15 AM

It's very hard to know who/what to believe about $CYDY. There seems to be so much conflicting info.

Cytodyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Tom Callahan 9/21/2020 7:43:40 PM

Good article, but my enthusiasm for $CYDY has really waned after reading some of Ketan Desai's comments.

CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Trinity Sinclair 9/2/2020 12:15:13 PM

When will your next article on $CYDY be out?

CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Terrence Howard 8/25/2020 6:02:04 PM

Ketan Desai, I think it's rare for authors to cover a stock with a completely unbiased view. Most write about a company because they feel strongly one way or the other.

Personally, I feel it's the reader's obligation to do some due diligence and seek out differing opinions and then make an informed decision on whether to invest. That's one of the reasons I love this site - I can read what different intelligent contributors have to say about the same stock. Unfortunately, there isn't much coverage on $CYDY. I think it would be great if you wrote an article about this stock as well so we could see some differing opinions. If you add up all your comments, the article is practically already written!

HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Trinity Sinclair 8/11/2020 11:45:59 PM

Is that Charlie Sheen in the video? Had no idea he had HIV. That's a pretty big endorsement he's giving $CYDY

CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
George Lipton 8/4/2020 9:08:14 PM

Thanks for replying, not all authors are considerate enough to do so. I'll be adding $CYDY to my watchlist.

CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Terrence Howard 8/4/2020 3:23:01 AM

Good update, keep the information coming on $CYDY

HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Stock Picks 7/19/2020 5:43:10 PM

There have been a number of great plays this year, but I think $CYDY takes the cake for #PlayoftheYear

1 to 10 of 20 comments
1 2